Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Venus Concept
(NASDAQ:VERO)
Intraday
$0.714
-0.0471
[-6.19%]
After-Hours
$0.714
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.714
-0.0471
[-6.19%]
At close: Apr 26
$0.714
0
[0.00%]
After Hours: 7:40PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Venus Concept Stock (NASDAQ:VERO)
Venus Concept Stock (NASDAQ: VERO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 08, 2024
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
Benzinga Newsdesk
-
Apr 8, 2024, 7:31AM
Wednesday, April 03, 2024
Venus Concept Received Therapeutic Goods Administration Clearance In Australia To Market The Venus Versa Pro System
Benzinga Newsdesk
-
Apr 3, 2024, 7:34AM
Monday, April 01, 2024
Venus Concept Expects Q1 FY24 Revenue Of At Least $16.5M Versus Consensus Of $19.37M
Benzinga Newsdesk
-
Apr 1, 2024, 7:05AM
Given Venus Concept's Dialogue With Existing Lenders And Investors And The Ongoing Evaluation Of Strategic Alternative, The Company Is Not Providing Full Year 2024 Financial Guidance
Benzinga Newsdesk
-
Apr 1, 2024, 7:04AM
Venus Concept Q4 GAAP EPS $(2.01) Misses $(1.18) Estimate, Sales $18.13M Miss $22.45M Estimate
Benzinga Newsdesk
-
Apr 1, 2024, 7:02AM
Earnings Scheduled For April 1, 2024
Benzinga Insights
-
Apr 1, 2024, 5:13AM
Monday, March 25, 2024
Venus Concept Received A Decision From The Nasdaq Hearings Panel Granting Its Request For Continued Listing On The Nasdaq Capital Market
Benzinga Newsdesk
-
Mar 25, 2024, 7:37AM
Tuesday, February 27, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Feb 27, 2024, 4:31PM
Monday, February 26, 2024
Gold Moves Lower; Pilgrim's Pride Earnings Top Views
Avi Kapoor
-
Feb 26, 2024, 2:30PM
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Feb 26, 2024, 1:57PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Feb 26, 2024, 12:31PM
Crude Oil Gains 1%; US New Home Sales Increase In January
Avi Kapoor
-
Feb 26, 2024, 12:01PM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Feb 26, 2024, 8:06AM
Friday, February 23, 2024
Venus Concept shares are trading lower after the company announced a $1.2 million registered direct offering at $1.465 per share.
Benzinga Newsdesk
-
Feb 23, 2024, 12:43PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Feb 23, 2024, 12:31PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Feb 23, 2024, 8:06AM
Venus Concept Announces $1.2M Registered Direct Offering Priced At $1.465/Share
Benzinga Newsdesk
-
Feb 23, 2024, 8:03AM
Thursday, February 22, 2024
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Feb 22, 2024, 1:37PM
Venus Concept shares are trading higher after the company announced it received the CE Mark from DEKRA Certification B.V. to market the Venus Versa Pro system in the European Union.
Benzinga Newsdesk
-
Feb 22, 2024, 10:16AM
Nasdaq Surges 300 Points; NVIDIA Posts Strong Results
Avi Kapoor
-
Feb 22, 2024, 9:47AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Feb 22, 2024, 8:05AM
Venus Concept Receives CE Mark From DEKRA Certification B.V. To Market Venus Versa Pro In Europe
Benzinga Newsdesk
-
Feb 22, 2024, 7:36AM
Tuesday, February 06, 2024
Venus Concept Awarded U.S. Patent #: 11890486 "Esthetic Apparatus Useful For Increasing Skin Rejuvenation And Methods Thereof"
Benzinga Newsdesk
-
Feb 6, 2024, 1:53PM
Venus Concept Awarded U.S. Patent #: 11890486 Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
Charles Gross
-
Feb 6, 2024, 1:51PM
Wednesday, January 24, 2024
Venus Concept Says Board Is Evaluating Potential Strategic Alternatives
Benzinga Newsdesk
-
Jan 24, 2024, 7:31AM
Tuesday, January 23, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jan 23, 2024, 8:06AM
Friday, January 19, 2024
Venus Concept Discloses Issuance of $2.0M Of Convertible Notes
Benzinga Newsdesk
-
Jan 19, 2024, 7:33AM
Thursday, January 18, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Jan 18, 2024, 12:31PM
Wednesday, January 17, 2024
Venus Concept Has Launched Venus Prime, A Structured In-house Financing Program Replacing Its Legacy Subscription Program For New Customers In North America
Benzinga Newsdesk
-
Jan 17, 2024, 7:32AM
Monday, January 15, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jan 15, 2024, 12:30PM
Monday, January 08, 2024
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Jan 8, 2024, 1:36PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jan 8, 2024, 12:30PM
Tuesday, November 14, 2023
Venus Concept Q3 EPS $(1.64) Misses $(1.51) Estimate, Sales $17.62M Beat $17.46M Estimate
Benzinga Newsdesk
-
Nov 14, 2023, 4:55PM
Earnings Scheduled For November 14, 2023
Benzinga Insights
-
Nov 14, 2023, 8:23AM
Thursday, October 12, 2023
Venus Concept Has Promoted Dr. Hemanth Varghese To The Newly Created Role Of President And Chief Operating Officer, Effective October 16.
Benzinga Newsdesk
-
Oct 12, 2023, 7:38AM
Friday, October 06, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
Benzinga Insights
-
Oct 6, 2023, 11:00AM
BTIG Downgrades Venus Concept to Neutral
Benzinga Newsdesk
-
Oct 6, 2023, 7:48AM
Thursday, October 05, 2023
Venus Concept Expects FY23 Revenue Of $80M-$82M Versus Prior Guidance Of $90M-$95M And Consensus Of $91.87M
Benzinga Newsdesk
-
Oct 5, 2023, 7:35AM
Venus Concept Expects Preliminary Q3 Revenue Of $17M-$18M Versus $21.5M A Year Ago; The Company Also Announces Debt Restructuring
Benzinga Newsdesk
-
Oct 5, 2023, 7:33AM
Thursday, September 14, 2023
Venus Concept Has Received A 510(K) Clearance From The FDA To Market Its Venus Versa Pro System, The Company's New Multi-application Platform, For Several Aesthetic And Cosmetic Procedures
Benzinga Newsdesk
-
Sep 14, 2023, 7:05AM
Friday, September 08, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 8, 2023, 1:58PM
Tuesday, September 05, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 5, 2023, 1:34PM
Monday, August 14, 2023
Venus Concept Q2 EPS $(1.35) Beats $(1.54) Estimate, Sales $20.10M Miss $20.67M Estimate
Benzinga Newsdesk
-
Aug 14, 2023, 4:21PM
Venus Concept Q2 EPS $(1.35) Beats $(1.54) Estimate
Benzinga Newsdesk
-
Aug 14, 2023, 4:13PM
Venus Concept Q2 Sales $20.10M Miss $20.67M Estimate
Benzinga Newsdesk
-
Aug 14, 2023, 4:13PM
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Aug 14, 2023, 1:48PM
Earnings Scheduled For August 14, 2023
Benzinga Insights
-
Aug 14, 2023, 6:45AM
Wednesday, August 09, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Aug 9, 2023, 12:27PM
Thursday, June 01, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Jun 1, 2023, 12:59PM
Friday, May 19, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
May 19, 2023, 1:59PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch